Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy
Arash Maleki,1,2 Neerav Lamba,1,2 Lina Ma,1,2 Stacey Lee,1,2 Alexander Schmidt,1,2 C Stephen Foster1–3 1Massachusetts Eye Research and Surgery Institution, 2Ocular Immunology and Uveitis Foundation, Waltham, 3Harvard Medical School, Boston, MA, USA Purpose: To examine the efficacy of rit...
Guardado en:
Autores principales: | Maleki A, Lamba N, Ma L, Lee S, Schmidt A, Foster CS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e1b21f8ad054e4580a80e31c6347d48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome
por: Carey,Elizabeth J, et al.
Publicado: (2011) -
Obligate and facultative paraneoplastic dermatoses: an overview
por: Stefano Caccavale, et al.
Publicado: (2018) -
Paraneoplastic myopathy in pancreatic cancer: a case report and literature review
por: Jessica Joanne Padniewski, et al.
Publicado: (2021) -
Update on Paraneoplastic Cerebellar Degeneration
por: Philipp Alexander Loehrer, et al.
Publicado: (2021) -
Anemia hemolítica autoinmune en Chile: un análisis retrospectivo de 43 pacientes
por: López-Vidal,Hernán, et al.
Publicado: (2019)